A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519

CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor that is being developed for dyslipidemia. Even though CKD-519 has shown potent CETP inhibition, the exposure of CKD-519 was highly varied, depending on food and dose. For highly variable exposure drugs, it is cruci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Choon Ok, Jeon, Sangil, Han, Seunghoon, Park, Min Soo, Yim, Dong-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356970/
https://www.ncbi.nlm.nih.gov/pubmed/32575566
http://dx.doi.org/10.3390/pharmaceutics12060573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356970/
https://www.ncbi.nlm.nih.gov/pubmed/32575566
http://dx.doi.org/10.3390/pharmaceutics12060573

Ejemplares similares